KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Times Interest Earned: 2019-2025

Historic Times Interest Earned for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Sep 2025 value amounting to $27.07.

  • Aurinia Pharmaceuticals' Times Interest Earned rose 178.30% to $27.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.81, marking a year-over-year increase of 341.70%. This contributed to the annual value of -$0.97 for FY2024, which is 97.07% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Times Interest Earned stood at $27.07, which was up 50.54% from $17.98 recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Times Interest Earned high stood at $27.07 for Q3 2025, and its period low was -$248.77 during Q2 2023.
  • Its 3-year average for Times Interest Earned is -$22.08, with a median of -$1.36 in 2024.
  • Data for Aurinia Pharmaceuticals' Times Interest Earned shows a peak YoY surged of 1,523.62% (in 2025) over the last 5 years.
  • Over the past 3 years, Aurinia Pharmaceuticals' Times Interest Earned (Quarterly) stood at -$22.65 in 2023, then soared by 93.57% to -$1.46 in 2024, then soared by 178.30% to $27.07 in 2025.
  • Its Times Interest Earned was $27.07 in Q3 2025, compared to $17.98 in Q2 2025 and $20.48 in Q1 2025.